Valuation (62%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -9.17 | N/A |
PEG Ratio (TTM) | 0.02 | N/A |
P/S Ratio (TTM) | 1.10 | N/A |
P/B Ratio (TTM) | 0.74 | N/A |
P/FCF Ratio (TTM) | -0.86 | N/A |
Price to 5YR AVG Earnings Ratio | 4.46 | N/A |
Price to 5YR AVG FCF Ratio | 4.66 | N/A |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | -2.02% | N/A |
ROE (TTM) | -7.86% | N/A |
Net Profit Margin (TTM) | -11.90% | N/A |
ROIC 5YR AVG | 14.48% | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -97.19% | 2,142.89% | 1,266.35% |
Revenue | -5.95% | 88.82% | 39.47% |
Net Income | -96.73% | 2,142.97% | 1,266.57% |
Cash Flow | -122.87% | -333.95% | -204.80% |
Health (61%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.31 | N/A |
Quick Ratio (TTM) | 2.31 | N/A |
D/E Ratio (TTM) | 0.55 | N/A |
Interest Coverage (TTM) | -0.50 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 0.64 | N/A |
LTL to 5YR AVG FCF | 2.55 | N/A |
Shares Outstanding Growth 5YR AVG | 0.32% | N/A |